Found: 9
Select item for more details and to access through your institution.
Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naïve patients with Gaucher disease.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 7, p. 656, doi. 10.1002/ajh.24369
- By:
- Publication type:
- Article
Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 7, p. 661, doi. 10.1002/ajh.24399
- By:
- Publication type:
- Article
Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteins
- Published in:
- Molecular Therapy, 2005, v. 12, n. 2, p. 274, doi. 10.1016/j.ymthe.2005.03.023
- By:
- Publication type:
- Article
342. Human Erythropoietin Gene Therapy for Patients with Chronic Renal Failure
- Published in:
- 2005
- By:
- Publication type:
- Abstract
A Plant-Derived Recombinant Human Glucocerebrosidase Enzyme -- A Preclinical and Phase I Investigation.
- Published in:
- PLoS ONE, 2009, v. 4, n. 3, p. 1, doi. 10.1371/journal.pone.0004792
- By:
- Publication type:
- Article
Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study.
- Published in:
- Orphanet Journal of Rare Diseases, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13023-023-02937-6
- By:
- Publication type:
- Article
Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1‐year Phase 1/2 clinical trial.
- Published in:
- Journal of Inherited Metabolic Disease, 2019, v. 42, n. 3, p. 534, doi. 10.1002/jimd.12080
- By:
- Publication type:
- Article
Immunogenicity of glycans on biotherapeutic drugs produced in plant expression systems—The taliglucerase alfa story.
- Published in:
- PLoS ONE, 2017, v. 12, n. 11, p. 1, doi. 10.1371/journal.pone.0186211
- By:
- Publication type:
- Article
Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system.
- Published in:
- Plant Biotechnology Journal, 2007, v. 5, n. 5, p. 579, doi. 10.1111/j.1467-7652.2007.00263.x
- By:
- Publication type:
- Article